Matricellular proteins: Potential biomarkers in head and neck cancer
Open Access
- 9 April 2024
- journal article
- review article
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 18 (2) , e12027
Abstract
The extracellular matrix (ECM) is a complex network of diverse multidomain macromolecules, including collagen, proteoglycans, and fibronectin, that significantly contribute to the mechanical properties of tissues. Matricellular proteins (MCPs), as a family of non‐structural proteins, play a crucial role in regulating various ECM functions. They exert their biological effects by interacting with matrix proteins, cell surface receptors, cytokines, and proteases. These interactions govern essential cellular processes such as differentiation, proliferation, adhesion, migration as well as multiple signal transduction pathways. Consequently, MCPs are pivotal in maintaining tissue homeostasis while orchestrating intricate molecular mechanisms within the ECM framework. The expression level of MCPs in adult steady‐state tissues is significantly low; however, under pathological conditions such as inflammation and cancer, there is a substantial increase in their expression. In recent years, an increasing number of studies have focused on elucidating the role and significance of MCPs in the development and progression of head and neck cancer (HNC). During HNC progression, there is a remarkable upregulation in MCP expression. Through their distinctive structure and function, they actively promote tumor growth, invasion, epithelial‐mesenchymal transition, and lymphatic metastasis of HNC cells. Moreover, by binding to integrins and modulating various signaling pathways, they effectively execute their biological functions. Furthermore, MCPs also hold potential as prognostic indicators. Although the star proteins of various MCPs have been extensively investigated, there remains a plethora of MCP family members that necessitate further scrutiny. This article comprehensively examines the functionalities of each MCP and highlights the research advancements in the context of HNC, with an aim to identify novel biomarkers for HNC and propose promising avenues for future investigations.Keywords
This publication has 161 references indexed in Scilit:
- OTUB1 inhibits breast cancer by non‐canonically stabilizing CCN6Clinical and Translational Medicine, 2023
- SPARC in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activityInternational Journal of Cancer, 2022
- Osteopontin Takes Center Stage in Chronic Liver DiseaseHepatology, 2020
- Wnt1‐inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1/TEAD1/GLUT1 pathwayJournal of Cellular Physiology, 2019
- MicroRNA‐384 regulates cell proliferation and apoptosis through directly targeting WISP1 in laryngeal cancerJournal of Cellular Biochemistry, 2018
- Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinomaCancer Medicine, 2015
- Plasminogen activator inhibitor‐1 as regulator of tumor‐initiating cell properties in head and neck cancersHead & Neck, 2015
- PAI‐1 in tissue fibrosisJournal of Cellular Physiology, 2011
- Plasma Osteopontin Levels in Patients With Head and Neck Cancer Undergoing ChemoradiotherapyJAMA Otolaryngology–Head & Neck Surgery, 2009
- Novel markers for poor prognosis in head and neck cancerInternational Journal of Cancer, 2004